Writing about Caribbean medical tourism tends to make the same three points. It’s cheaper. It’s close. The beaches are nice.
A short paper published on LinkedIn in February makes a harder argument. The CALA Restorative Collective writes that luxury medical travel has been misread — that it isn’t about marble lobbies or cosmetic work, but about “discretion, time, personal attention, comfort, and control over the care experience.” On that definition, the Caribbean has advantages larger destinations can’t easily copy.
Their sharpest line is about positioning, not medicine. “What has limited the Caribbean’s visibility in this space is not capability but narrative,” they write.
That diagnosis is correct. The region has spent decades selling itself as somewhere to go rather than somewhere to be treated, and when it has sold healthcare it has sold it on price — the one thing it was never going to win on.
The conclusion they draw from that is where this needs a harder look.
The case they make
Strip the paper back and four claims remain.
Proximity reduces strain. A patient flying from Miami is in the air about ninety minutes, lands in the same time zone, speaks the same language, and fills in no visa forms. For someone frightened and unwell, that ease is part of what they’re paying for. Hard to argue with.
Small settings allow real personalisation. Longer consultations, direct access to the surgeon who will actually operate, one coordinator across the whole case. The paper puts this better than most trade writing manages: patients paying privately “expect to be known, not processed.”
Environment affects recovery. Quiet, natural light, privacy, sea air. The authors call this “difficult to quantify” and move on, which undersells their own point — there is published research on hospital environment and recovery they could have cited.
Discretion is a product in itself. Executives and public figures want treatment without visibility, and a small island offers anonymity that a large hospital in a major city cannot.
Then the argument turns. Rather than compete with the big hubs on volume or price, the paper says, the Caribbean should specialise in “curated, high-touch” care — “fewer patients, deeper relationships, higher expectations.” The closing line is the one to argue with: luxury emerges, they write, “when scale gives way to intention.”
Where the argument meets the evidence
Scale isn’t only a commercial variable in surgery. It’s a clinical one.
The link between how often a hospital performs a procedure and how well its patients do is among the sturdier findings in health services research. Teams doing an operation weekly tend to have lower complication and mortality rates than teams doing it monthly. The effect is largest where the stakes are highest — cardiac surgery, cancer resections, complex orthopaedics.
So “fewer patients” isn’t a clean trade against “deeper relationships.” For some procedures it trades against survival.
That doesn’t sink the argument. It splits it.
For one category of care the model holds up: diagnostics, executive health assessment, elective procedures with settled pathways, rehabilitation, and follow-on care after surgery performed somewhere else. Low-volume and high-touch suits that work, and it may be the region’s real opening.
For high-acuity surgery it’s a much harder sell, and a patient reading this paper should be asking how many of their operation the surgeon performed last year.
The paper doesn’t separate the two. That separation is the whole question for anyone deciding where to have something serious done.
What the region has actually built
The Caribbean’s flagship facility complicates the small-is-better framing, and it’s worth describing for that reason.
Health City Cayman Islands opened in February 2014 in East End, Grand Cayman. Its founder is Dr. Devi Shetty, the Indian cardiac surgeon whose Narayana Health group became known for performing heart surgery at volumes and prices Western systems couldn’t match. The hospital runs 104 beds across 107,000 square feet, holds JCI accreditation, and was built to keep operating through a Category 5 hurricane. It covers cardiac surgery, oncology, orthopaedics, neurosurgery and paediatrics, and runs a cancer centre in collaboration with Dana-Farber Cancer Institute.
Note what it isn’t. Shetty’s reputation was built on doing more, not less. The Caribbean’s most serious medical tourism asset was founded on a philosophy close to the opposite of scale giving way to intention.
Rebekah Brooks, who heads marketing, sales and international services there, described the draw this July in terms nearer to CALA’s framing than to a price list. “Patients are travelling for quality, trust, convenience, and peace of mind,” she said, “and that’s what we strive to deliver.”
Brooks worked in intensive care before moving into executive roles, and her second remark is the one to pin above a desk if you’re selling recovery experiences. “Working in intensive care teaches you that behind every diagnosis is a person,” she said, “and behind every patient is a family.”
The question the paper leaves out
There is no mention of the people who live there.
Researchers have looked at this. Repeatedly. A 2015 study in WIMJ Open by Hoffman, Crooks, Snyder and Adams examined health equity effects across Jamaica, the Cayman Islands, Barbados and St Lucia, and found the same three tensions in every one.
Medical tourism creates training and jobs for local health workers, and pulls them out of the public system, widening the gap between public and private care. Private facilities expand what’s available locally, and can displace existing providers while pricing out residents. Foreign patients could in principle help fund public healthcare — the researchers found the opposite risk, that money and attention drift toward the part of the system serving visitors.
Their most pointed finding was about the silence around all this. Caribbean stakeholders understand both the opportunity and the danger, they wrote, but aren’t getting clear guidance on how to handle the trade-off.
Eleven years later, a paper proposing a regional strategy still doesn’t raise it. A model built on treating fewer patients at higher prices makes those questions sharper, not softer.
What the paper doesn’t say about itself
It contains no numbers. Not one patient volume, price, accreditation count, hospital name or country. Every claim is asserted. A piece arguing that a region has been mispositioned offers no evidence that the demand it describes exists, and that absence is what separates it from a market analysis.
CALA Restorative Collective also sells into this segment. The paper identifies “emerging recovery-focused accommodation models” and coordinated aftercare as the Caribbean’s opportunity, which is a description of the business publishing it. That doesn’t make the argument wrong — operators often see a market before analysts do. It does mean reading it as advocacy, and the authors don’t say so.
What the model would need to work
On one point the paper is right, and it’s the part that’s hardest to actually deliver. “Luxury patients are highly sensitive to inconsistencies,” it says. “A single weak link can undermine trust across the entire journey.”
That weak link is almost never the operation.
A patient flies home a week after surgery. Three weeks later something is wrong — a wound that won’t close, a fever, pain in the wrong place. Their doctor at home has no operative notes, no imaging, no contact with the surgical team, and limited enthusiasm for managing another surgeon’s complication.
Proximity is the Caribbean’s strongest answer to that, and the paper undersells it. A patient two hours from Miami can fly back for review. A patient who went to Kuala Lumpur cannot.
The advantage only counts if the pathway is written down before booking: who to call, in which country, at whose expense, and which records travel home with the patient. Any programme charging premium prices should put that in writing without being asked.
Why it matters
North American patients have no closer option than the Caribbean, and twelve years after its flagship hospital opened, no second facility of that seriousness has followed. If curated and high-touch is the strategy, it has to name which procedures it covers — and which ones still belong somewhere with volume behind them.
What to watch
- Whether any Caribbean health ministry publishes actual inbound medical travel figures rather than projections.
- Whether recovery-accommodation operators publish clinical governance arrangements — who is responsible when a guest deteriorates, and what the escalation route is.
- Whether a regional standard emerges for the aftercare handover, which is where this market is thinnest.
